Perrigo Co PLC (PRGO)
30.59
+0.10
(+0.33%)
USD |
NYSE |
Apr 24, 13:48
Perrigo Free Cash Flow: 303.80M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | 303.80M |
September 30, 2023 | 281.30M |
June 30, 2023 | 226.50M |
March 31, 2023 | 148.30M |
December 31, 2022 | 210.90M |
September 30, 2022 | -95.70M |
June 30, 2022 | 168.20M |
March 31, 2022 | 108.20M |
December 31, 2021 | 4.20M |
September 30, 2021 | 195.60M |
June 30, 2021 | -87.30M |
March 31, 2021 | 282.60M |
December 31, 2020 | 465.80M |
September 30, 2020 | 463.60M |
June 30, 2020 | 549.10M |
March 31, 2020 | 314.70M |
December 31, 2019 | 250.10M |
September 30, 2019 | 356.50M |
June 30, 2019 | 372.60M |
March 31, 2019 | 404.80M |
December 31, 2018 | 490.40M |
September 30, 2018 | 525.40M |
June 30, 2018 | 583.60M |
March 31, 2018 | 596.80M |
December 31, 2017 | 610.30M |
Date | Value |
---|---|
September 30, 2017 | 611.40M |
June 30, 2017 | 624.20M |
March 31, 2017 | 585.60M |
December 31, 2016 | 548.70M |
September 30, 2016 | 461.50M |
June 30, 2016 | 332.40M |
March 31, 2016 | 531.50M |
December 31, 2015 | |
September 30, 2015 | 652.20M |
June 30, 2015 | 718.20M |
March 31, 2015 | 836.40M |
December 31, 2014 | 738.60M |
September 30, 2014 | 566.50M |
June 30, 2014 | 461.40M |
March 31, 2014 | 413.90M |
December 31, 2013 | 401.90M |
September 30, 2013 | 477.90M |
June 30, 2013 | 449.70M |
March 31, 2013 | 484.64M |
December 31, 2012 | 419.04M |
September 30, 2012 | 388.11M |
June 30, 2012 | 393.20M |
March 31, 2012 | 317.26M |
December 31, 2011 | 346.88M |
September 30, 2011 | 325.15M |
Free Cash Flow Range, Past 5 Years
-95.70M
Minimum
Sep 2022
549.10M
Maximum
Jun 2020
237.84M
Average
250.10M
Median
Dec 2019
Free Cash Flow Benchmarks
Alkermes PLC | 353.30M |
Endo International PLC | 340.77M |
Jazz Pharmaceuticals PLC | 1.049B |
Medtronic PLC | 4.931B |
Iterum Therapeutics PLC | -39.34M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 208.70M |
Cash from Investing (Quarterly) | -22.80M |
Cash from Financing (Quarterly) | -44.60M |
Free Cash Flow Per Share (Quarterly) | 1.342 |
Free Cash Flow to Equity (Quarterly) | 195.20M |
Free Cash Flow to Firm (Quarterly) | 203.78M |
Free Cash Flow Yield | 7.30% |